Related Experiment Video

Updated: Jul 20, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

Severe pseudomonal infections

Gökhan M Mutlu1, Richard G Wunderink

  • 1Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.

Current Opinion in Critical Care
|September 1, 2006
PubMed
Abstract

Insights

Severe Pseudomonas aeruginosa infections are increasing in hospitalized patients, with emerging pan-resistant strains leading to higher mortality. Early broad-spectrum antibiotic therapy and accurate diagnostics are crucial for managing these critical infections.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Antimicrobial Resistance

Background:

  • Pseudomonas aeruginosa is a significant cause of hospital-acquired infections.
  • Increasing rates of multidrug-resistant strains pose a growing clinical challenge.
  • These infections are associated with substantial morbidity and mortality in hospitalized patients.

Purpose of the Study:

  • To review recent clinical data on severe Pseudomonas aeruginosa infections.
  • To focus on infections in critically ill patients.
  • To highlight challenges posed by antimicrobial resistance.

Main Methods:

  • Literature review of recent clinical studies.
  • Analysis of data on Pseudomonas aeruginosa infection frequency and resistance patterns.
  • Evaluation of treatment outcomes and prevention strategies.

Main Results:

  • P. aeruginosa infections are increasing, with a rise in pan-resistant isolates.
  • Pan-resistant strains are linked to higher rates of inappropriate initial therapy and increased mortality.
  • Antibiotic class rotation has not effectively reduced resistant isolates; treatment protocols may increase selection pressure.

Conclusions:

  • Empiric broad-spectrum antibiotic therapy is recommended for suspected P. aeruginosa infections due to resistance and mortality rates.
  • Accurate diagnostics are vital to de-escalate antibiotic use and reduce selective pressure.
  • Future strategies must focus on optimizing current antibiotic use and developing innovative treatments given the lack of new antibiotic classes.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...